• C difficile infections market to hit $1.7bn by 2026 europeanpharmaceuticalreview
    July 28, 2017
    GlobalData latest report states that the major drivers of this growth include the projected launch of prophylactic options for the prevention of Clostridium difficile infections…
PharmaSources Customer Service